HLN:LSEHaleon PLC Analysis
Data as of 2026-06-12 - not real-time
£336.80
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical signals show a mixed picture: the 20‑day SMA (≈336) trails the 50‑day (≈344) and 200‑day (≈361) averages, indicating a long‑term bearish trajectory, while the MACD (line = ‑2.66, signal = ‑3.83) and a positive histogram suggest a short‑term bullish push. The RSI sits at 49.4, hovering just below the neutral 50 mark, and volume is on an upward trend, but the 30‑day volatility of 23.7% and an “Extreme Greed” sentiment index (89.09) signal heightened market risk.
Valuation and fundamentals show a nuanced stance: the current P/E of 17.7 is well below the industry average of 24.8, and the forward P/E falls to 14.9, suggesting value appeal, yet the discounted‑cash‑flow fair value (≈130) is dramatically lower than the present price (≈337), flagging a potential over‑extension. The dividend yield of 2.13% with a 36.8% payout ratio is sustainable, and the profit margin (15.1%) and ROE (10.3%) remain respectable despite a modest revenue growth of 0.6% and a debt‑to‑equity ratio of 52%.
Valuation and fundamentals show a nuanced stance: the current P/E of 17.7 is well below the industry average of 24.8, and the forward P/E falls to 14.9, suggesting value appeal, yet the discounted‑cash‑flow fair value (≈130) is dramatically lower than the present price (≈337), flagging a potential over‑extension. The dividend yield of 2.13% with a 36.8% payout ratio is sustainable, and the profit margin (15.1%) and ROE (10.3%) remain respectable despite a modest revenue growth of 0.6% and a debt‑to‑equity ratio of 52%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish SMA hierarchy and high 30‑day volatility
- Positive MACD crossover but limited upside
- Sustainable dividend offsetting market risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued P/E relative to industry
- Strong oral‑health segment growth reported
- Stable cash flow and modest debt load
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent dividend and payout sustainability
- Broad international footprint reducing single‑region risk
- Long‑term demand for consumer health products
Key Metrics & Analysis
Financial Health
Revenue Growth0.60%
Profit Margin15.11%
P/E Ratio17.7
ROE10.27%
ROA4.67%
Debt/Equity52.37
P/B Ratio1.8
Op. Cash Flow£2.6B
Free Cash Flow£1.4B
Industry P/E24.8
Technical Analysis
TrendBearish
RSI49.4
Support£317.80
Resistance£346.70
MA 20£335.88
MA 50£344.46
MA 200£361.38
MACDBullish
VolumeIncreasing
Fear & Greed Index89.09
Valuation
Fair Value£129.82
Target Price£417.47
Upside/Downside23.95%
GradeOvervalued
TypeBlend
Dividend Yield2.13%
Risk Assessment
Beta-0.18
Volatility23.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.